Phytochemical profile and therapeutic potential of Viscum album L.
暂无分享,去创建一个
[1] Edited,et al. Herbal drugs and phytopharmaceuticals , 2016 .
[2] E. Supriyanto,et al. Preclinical and Clinical Effects of Mistletoe against Breast Cancer , 2014, BioMed research international.
[3] O. Effiong. Reduction in Serum Bilirubin Concentration Following Administration of Crude Leaf Extract of Viscum album (Mistletoe) in High Salt Fed Rats , 2014 .
[4] M. Milićević,et al. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. , 2013, European journal of cancer.
[5] J. Simard,et al. Viscum album agglutinin-I (VAA-I) increases cell surface expression of cytoskeletal proteins in apoptotic human neutrophils , 2013, Human & experimental toxicology.
[6] G. Francis,et al. Novel GHB-derived natural products from European mistletoe (Viscum album) , 2013, Pharmaceutical biology.
[7] G. Kienle,et al. Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts--a case report. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[8] Hwa-Young Lee,et al. Stereochemical assignment of five new lignan glycosides from Viscum album by NMR study combined with CD spectroscopy , 2012, Magnetic resonance in chemistry : MRC.
[9] C. Schempp,et al. A Novel Triterpene Extract from Mistletoe Induces Rapid Apoptosis in Murine B16.F10 Melanoma Cells , 2012, Phytotherapy research : PTR.
[10] G. Francis,et al. Novel aminoalkaloids from European mistletoe (Viscum album L.) , 2012 .
[11] Mahfoozur Rahman,et al. Sedative, antiepileptic and antipsychotic effects of Viscum album L. (Loranthaceae) in mice and rats. , 2012, Journal of ethnopharmacology.
[12] O. Adaramoye,et al. Methanolic extract of African mistletoe (Viscum album) improves carbohydrate metabolism and hyperlipidemia in streptozotocin-induced diabetic rats. , 2012, Asian Pacific journal of tropical medicine.
[13] P. Perjési,et al. Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence based medicine , 2012 .
[14] G. Henze,et al. A new development of triterpene acid‐containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia , 2012, Cell proliferation.
[15] C. Socaciu,et al. Antioxidant Activity of European Mistletoe (Viscum album) , 2012 .
[16] Dvc Awang. Mosby's Handbook of Herbs and Natural Supplements , 2011 .
[17] S. Kaveri,et al. Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2 , 2011, PloS one.
[18] H. Kiene,et al. Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters , 2011, BMC complementary and alternative medicine.
[19] A. Pintea,et al. HPLC Fingerprint of Bioactive Compounds and Antioxidant Activities of Viscum album from Different Host Trees , 2011 .
[20] A. Moghadamnia,et al. Antihyperglycemic and antioxidant activity of Viscum album extract , 2011 .
[21] M. Choudhary,et al. Characterization and Antiglycation Activity of Phenolic Constituents from Viscum album (European Mistletoe) , 2010 .
[22] A. Sleem,et al. Effect of Viscum album on acute hepatic damage caused by carbon tetrachloride in rats , 2010, Turkish Journal of Medical Sciences.
[23] H. Kiene,et al. Review Article: Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies , 2010, Integrative cancer therapies.
[24] J. Bao,et al. Plant lectins: potential antineoplastic drugs from bench to clinic. , 2010, Cancer letters.
[25] S. Kaveri,et al. Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity. , 2009, Anticancer research.
[26] R. Saller,et al. Efficacy and Safety of Mistletoe Preparations (Viscum album) for Patients with Cancer Diseases , 2009, Complementary Medicine Research.
[27] H. Kiene,et al. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research , 2009, Journal of experimental & clinical cancer research : CR.
[28] N. E. Gardin. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four‐case series , 2009, Phytotherapy research : PTR.
[29] S. Branković,et al. Effects of Mistletoe (Viscum Album L., Loranthaceae) Extracts on Arterial Blood Pressure in Rats Treated with Atropine Sulfate and Hexocycline , 2009, Clinical and experimental hypertension.
[30] M. Popović,et al. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo , 2008, Phytotherapy research : PTR.
[31] K. Linde,et al. Mistletoe therapy in oncology. , 2008, The Cochrane database of systematic reviews.
[32] U. Pfüller,et al. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. , 2007, Planta medica.
[33] A. Eno,et al. Effect of crude aqueous leaf extract of Viscum album (mistletoe) in hypertensive rats , 2007 .
[34] N. Arda,et al. Antioxidant activity of Viscum album ssp. album. , 2006, Fitoterapia.
[35] S. Kaveri,et al. Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma. , 2006, Cancer letters.
[36] E. Kuepeli,et al. Anti-Inflammatory and Antinociceptive Activity of Flavonoids Isolated from Viscum album ssp. album , 2006, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[37] J. van Hattum,et al. Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C. , 2011, Arzneimittel-Forschung.
[38] U. Pfüller,et al. Complete structure determination of the A chain of mistletoe lectin III from Viscum album L. ssp. album , 2004, Journal of peptide science : an official publication of the European Peptide Society.
[39] A. Serrano,et al. Transfer of bipiperidyl and quinolizidine alkaloids toViscum cruciatum Sieber (Loranthaceae) hemiparasitic onRetama sphaerocarpa boissier (Leguminosae) , 1993, Journal of Chemical Ecology.
[40] B. Schneider,et al. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological coh , 2004, Arzneimittel-Forschung.
[41] K. Schmidt,et al. Mistletoe for cancer? , 2003, International journal of cancer.
[42] N. Arda,et al. Antiviral potency of mistletoe (Viscum album ssp. album) extracts against human parainfluenza virus type 2 in Vero cells , 2003, Phytotherapy research : PTR.
[43] F. Berrino,et al. Mistletoe in cancer - a systematic review on controlled clinical trials. , 2003, European journal of medical research.
[44] C. Esimone,et al. Hypoglycemic Properties of Viscum album (Mistletoe) in Alloxan-induced Diabetic Animals , 2003 .
[45] Ö. Ertürk. Antimicrobial Activity of Viscum album L. subsp. abietis (Wiesb) , 2003 .
[46] Markus Bauer,et al. Cuticular Waxes and Flavonol Aglycones of Mistletoes , 2003, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[47] İ. Çalış,et al. Two New Flavonoid Glycosides from Viscum album ssp. album , 2002 .
[48] E. Ernst. Cancer therapy with mistletoe:hope or hype? , 2002, Journal of herbal pharmacotherapy.
[49] A. Piotrowski,et al. Comparative analysis of phenolic acids in mistletoe plants from various hosts. , 2001, Acta poloniae pharmaceutica.
[50] L. Skidmore-Roth. Mosby's Handbook of Herbs & Natural Supplements , 2001 .
[51] B. Şener,et al. Evaluation of Antimycobacterial Activity of Viscum album Subspecies , 2001 .
[52] E. Ernst. Mistletoe for cancer? , 2001, European journal of cancer.
[53] U. Pfüller. Chemical Constituents of European Mistletoe (Viscum album L.) Isolation and Characterisation of the Main Relevant Ingredients: Lectins, Viscotoxins, Oligo-/polysaccharides, Flavonoides, Alkaloids , 2000 .
[54] A. Büssing. INTRODUCTION: HISTORY OF MISTLETOE USES , 2000 .
[55] C. K. Buharalioglu,et al. Studies on the vascular effects of the fractions and phenolic compounds isolated from Viscum album ssp. album. , 2000, Journal of ethnopharmacology.
[56] C. Hyun,et al. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album). , 1999, Cancer letters.
[57] P. Flatt,et al. Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). , 1999, The Journal of endocrinology.
[58] İ. Çalış,et al. THE COMPARATIVE STUDIES ON PHENYLPROPANOID GLYCOSIDES OF VISCUM ALBUM SUBSPECIES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY , 1999 .
[59] M. Giannattasio,et al. Viscotoxin composition of the three European subspecies of Viscum album. , 1998, Planta medica.
[60] A. Multani,et al. Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations. , 1998, Cancer letters.
[61] B. Geils,et al. Hosts of Viscum album , 1998 .
[62] C. Mayr,et al. Pharmacological activity of phenylpropanoids of the mistletoe, Viscum album L., host: Pyrus caucasica Fed. , 1998, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[63] A. B. ssing. Mistletoe therapy and immunological research , 1997 .
[64] P. Poindron,et al. Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. , 1996, Cancer letters.
[65] P. Verhaert,et al. Isolation and partial characterization of a small chitin‐binding lectin from mistletoe (Viscum album) , 1996, FEBS letters.
[66] M. Giannattasio,et al. Cytotoxicity of Different Viscotoxins and Extracts from the European Subspecies of Viscum album L. , 1996 .
[67] Prof. Robert Hegnauer. Chemotaxonomie der Pflanzen , 1996, Lehrbücher und Monographien aus dem Gebiete der Exakten Wissenschaften.
[68] N. Bisset. Herbal drugs and phytopharmaceuticals , 1994 .
[69] N. Žarković,et al. Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel. , 1993, Oncology.
[70] H. Itokawa,et al. Studies on the Constituents of the European Mistletoe, Viscum album L. II , 1987 .
[71] H. Wagner,et al. Structure and properties of polysaccharides from Viscum album (L.). , 1986, Oncology.
[72] H. Wagner,et al. Phenylpropanes and lignans of Viscum album cardioactive drugs V. , 1986, Planta medica.
[73] H. Franz. Inhaltsstoffe der Mistel (Viscum album L.) als potentielle Arzneimittel , 1985 .